Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3lij | ANP | Calcium/calmodulin dependent protein kinase with a kinase domain and 4 calmodulin like EF hands | / | 1.000 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.577 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.556 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.554 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.542 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.534 | |
4bl1 | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.529 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.525 | |
3t8o | ATP | Rhodopsin kinase | / | 0.519 | |
4ysj | ADP | Calmodulin-like domain protein kinase | / | 0.518 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.517 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.517 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.515 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.515 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.514 | |
3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.513 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.512 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.511 | |
3c4x | ATP | Rhodopsin kinase | / | 0.511 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.511 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.510 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.508 | |
3q5i | ANP | Protein kinase, putative | / | 0.508 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.506 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.505 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.505 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.505 | |
4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.505 | |
2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
3qc9 | ADP | Rhodopsin kinase | / | 0.504 | |
4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.503 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.502 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.501 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.501 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.501 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.500 | |
5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.500 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.499 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.498 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.498 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.497 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.497 | |
2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.497 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.496 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.496 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.496 | |
3zxt | ACP | Death-associated protein kinase 1 | 2.7.11.1 | 0.496 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.496 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.495 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.495 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.495 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
1zao | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.494 | |
2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.494 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.494 | |
4qny | ANP | Mitogen activated protein kinase, putative | / | 0.494 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.493 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.493 | |
4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.492 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.492 | |
3bhy | 7CP | Death-associated protein kinase 3 | / | 0.491 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.491 | |
1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.490 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.490 | |
4b8l | A0P | Aurora kinase B-A | 2.7.11.1 | 0.490 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 0.489 | |
3c4w | ATP | Rhodopsin kinase | / | 0.489 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.489 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.489 | |
5eg3 | ACP | Fibroblast growth factor receptor 2 | / | 0.489 | |
3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.488 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.488 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.487 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.487 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.487 | |
3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.487 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.487 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.486 | |
4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.486 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.486 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.486 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.485 | |
4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.485 | |
2pul | ACP | Methylthioribose kinase | 2.7.1.100 | 0.484 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.484 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.484 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.484 | |
4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.484 | |
2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.483 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.483 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.482 | |
4gt3 | ATP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.482 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.481 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.481 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.480 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.480 | |
4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.480 | |
4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.480 | |
4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.480 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.480 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.479 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.479 | |
2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.479 | |
3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.479 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.478 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.478 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.478 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.478 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.478 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.477 | |
4fsu | HK5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.477 | |
1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.476 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.476 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.476 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.476 | |
4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.476 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.476 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.475 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.475 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.475 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.475 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
3t2k | FAD | Sulfide-quinone reductase | / | 0.474 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.474 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.474 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.473 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.473 | |
3t14 | FAD | Sulfide-quinone reductase | / | 0.473 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.473 | |
1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.472 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.472 | |
4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
4fv8 | E63 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.472 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.472 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.471 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.471 | |
1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.471 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.471 | |
3q92 | XNB | Ketohexokinase | / | 0.471 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.471 | |
4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.471 | |
4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.471 | |
2bmc | MPY | Aurora kinase A | 2.7.11.1 | 0.470 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.470 | |
2w4j | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.470 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.470 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.470 | |
3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.470 | |
4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.470 | |
1ee0 | CAA | 2-pyrone synthase | / | 0.469 | |
1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.469 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.469 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.469 | |
4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.469 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.469 | |
4qo9 | 627 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.469 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.468 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
3pls | ANP | Macrophage-stimulating protein receptor | 2.7.10.1 | 0.468 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.468 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.468 | |
1cm8 | ANP | Mitogen-activated protein kinase 12 | / | 0.467 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.467 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.466 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.466 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.465 | |
2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.465 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
3nup | 3NU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.465 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.465 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.465 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.464 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.464 | |
3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
3qx2 | X63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.464 | |
4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.464 | |
5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.464 | |
5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.464 | |
5cvf | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
5g3s | FDA | Flavin-dependent L-tryptophan oxidase VioA | / | 0.464 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.463 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.463 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.463 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.463 | |
4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.463 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.463 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.463 | |
1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.462 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.462 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.462 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.462 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.462 | |
3c4z | ADP | Rhodopsin kinase | / | 0.462 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.462 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.462 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.462 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
1jkk | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.461 | |
2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.461 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.461 | |
3qai | XNN | Ketohexokinase | / | 0.461 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.461 | |
4wbo | ANW | Rhodopsin kinase | / | 0.461 | |
1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.460 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
4d58 | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.460 | |
4fg9 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.460 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.459 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.459 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.459 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.459 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.458 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.458 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.458 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.458 | |
3qxp | X64 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
3tvu | B37 | Acetyl-CoA carboxylase | / | 0.458 | |
3w0p | ADP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.458 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.458 | |
4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.458 | |
4l7f | 1V5 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.458 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.457 | |
4eol | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.457 | |
4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.457 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.456 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.456 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.456 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.456 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.456 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.456 | |
3tuc | FPW | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.456 | |
4a9s | RU9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.456 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.456 | |
1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.455 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
2wtj | WTJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
3cok | ANP | Serine/threonine-protein kinase PLK4 | 2.7.11.21 | 0.455 | |
3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.454 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.454 | |
2uzu | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.454 | |
3eig | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
3kkv | B99 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.454 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.454 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.454 | |
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.453 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.453 | |
2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.453 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.453 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.453 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.453 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.453 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.453 | |
4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.453 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
1i44 | ACP | Insulin receptor | 2.7.10.1 | 0.452 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.452 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.452 | |
3orp | AGS | Serine/threonine protein kinase | / | 0.452 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
4bdc | ODH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.452 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.452 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.452 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.452 | |
1ig1 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.451 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.451 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.451 | |
4jik | 1KO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.451 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.451 | |
4wbb | ADP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.451 | |
4wlo | NAI | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.451 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
1q99 | ANP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.450 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.450 | |
2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.450 | |
2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
3ekp | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
3hwr | NDP | 2-dehydropantoate 2-reductase | / | 0.450 | |
3r9n | Z68 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
3v01 | 3V0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.450 | |
4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
5cu6 | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
1bwb | 146 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
1s9j | BBM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.449 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.449 | |
2i4z | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
3cif | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.449 | |
3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.449 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.449 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.449 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
4wlu | NAD | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.449 | |
5ap7 | SVE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.449 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
3gc8 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.448 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.448 | |
4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.448 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.448 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
4n57 | ADP | APH(2'')-Id | / | 0.448 | |
5dqr | FAD | 7-hydroxymethyl chlorophyll a reductase, chloroplastic | 1.17.7.2 | 0.448 | |
1rkx | NAD | CDP-D-glucose-4,6-dehydratase | / | 0.447 | |
1z5m | LI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
2qhc | AB1 | Protease | / | 0.447 | |
2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
3cqw | CQW | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.447 | |
3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.447 | |
3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
3ogq | AB1 | Pol polyprotein | / | 0.447 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.447 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.447 | |
4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.447 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.447 | |
4j98 | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
4l44 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.447 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.447 | |
5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.447 | |
5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.447 | |
5g3t | FDA | Flavin-dependent L-tryptophan oxidase VioA | / | 0.447 | |
1mq4 | ADP | Aurora kinase A | 2.7.11.1 | 0.446 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.446 | |
2qd7 | 065 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
2uxz | HI1 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.446 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
3dho | B2M | Streptogramin A acetyltransferase | 2.3.1 | 0.446 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.446 | |
3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.446 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
4d4s | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.446 | |
4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.446 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.446 | |
5auv | AGI | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
1e8w | QUE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
1fvt | 106 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
1ie4 | T44 | Transthyretin | / | 0.445 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
1qbt | 146 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
1ydt | IQB | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
2p5u | NAD | UDP-glucose 4-epimerase | / | 0.445 | |
2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.445 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
3nu3 | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
3r71 | X86 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.445 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.445 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.445 | |
1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.444 | |
1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1ivq | 0PX | Gag-Pol polyprotein | / | 0.444 | |
1q8u | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.444 | |
1v9a | SAH | Uncharacterized protein | / | 0.444 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.444 | |
2y02 | Y01 | Beta-1 adrenergic receptor | / | 0.444 | |
3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.444 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.444 | |
3sz0 | FAD | Sulfide-quinone reductase | / | 0.444 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
3wd7 | COA | Acridone synthase | / | 0.444 | |
4fyn | 0VE | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.444 | |
4fz6 | 0VG | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.444 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
4hdb | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
4xcv | NDP | Probable hydroxyacid dehydrogenase protein | / | 0.444 | |
1db1 | VDX | Vitamin D3 receptor | / | 0.443 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1ohr | 1UN | V-1 PROTEASE protein | / | 0.443 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
2aid | THK | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
2avv | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.443 | |
2i0a | MUI | Protease | / | 0.443 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
2r3w | G3G | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
2vts | LZC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.443 | |
3s2a | 2NQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.443 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.443 | |
1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
1rrm | APR | Lactaldehyde reductase | 1.1.1.77 | 0.442 | |
1w2x | RCP | Acetyl-CoA carboxylase | / | 0.442 | |
2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.442 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
3em6 | 017 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
3nwy | GTP | Uridylate kinase | / | 0.442 | |
3ort | AGS | Serine/threonine protein kinase | / | 0.442 | |
3p23 | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.442 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4fk1 | FAD | Putative thioredoxin reductase | / | 0.442 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.442 | |
4nif | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.442 | |
4wq5 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.442 | |
1z1h | HBB | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
2bpy | 3IN | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.441 | |
2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.441 | |
2pe0 | 39Z | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.441 | |
2wle | COA | Polysialic acid O-acetyltransferase | / | 0.441 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.441 | |
3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
3opd | HIE | Heat shock protein 83 | / | 0.441 | |
3qcx | 3Q2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.441 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.441 | |
4cy8 | FDA | 2-hydroxybiphenyl-3-monooxygenase | / | 0.441 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.441 | |
4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.441 | |
4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.441 | |
4x4j | FAD | Putative oxygenase | / | 0.441 | |
1b6k | PI5 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
1q8y | ADP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.440 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.440 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.440 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.440 | |
3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.440 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.440 | |
4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.440 | |
4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 |